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The chromatoid body is a perinuclear, cytoplasmic cloud-like struc-
ture in male germ cells whose function has remained elusive. Here
we show that the chromatoid body is related to the RNA-process-
ing body of somatic cells. Dicer and components of microRNP
complexes (including Ago proteins and microRNAs) are highly
concentrated in chromatoid bodies. Furthermore, we show that
Dicer interacts with a germ cell-specific chromatoid body compo-
nent, the RNA helicase MVH (mouse VASA homolog). Thus, chro-
matoid bodies seem to operate as intracellular nerve centers of the
microRNA pathway. Our findings underscore the importance of
posttranscriptional gene regulation and of the microRNA pathway
in the control of postmeiotic male germ cell differentiation.
Argonaute  microRNA  spermatogenesis  RNA processing
The complex and highly elaborated differentiation program ofmale germ cells involves multiple and finely tuned levels of
gene control (1). During late steps of spermiogenesis there is a
striking cessation of transcription, occuring in concert with
drastic epigenetic modifications that result in chromatin com-
paction (2). Concomitantly there are extensive posttranscrip-
tional storing and processing of mRNAs (3).
RNA interference (RNAi) and microRNA (miRNA) path-
ways are evolutionarily conserved control mechanisms that use
RNA molecules to inhibit gene expression at the level of mRNA
degradation, translational repression, or chromatin modification
and silencing (4–6). RNAi has been shown to be present
throughout spermatogenesis in mice (7), but its function and
cellular control during germ cell development remain uncertain.
Two classes of 21- to 25-nt small RNAs, small interfering
RNAs (siRNAs) and miRNAs, act as sequence-specific regula-
tors of gene expression (5). siRNAs mediate degradation of
mRNAs having sequences fully complementary to their se-
quence, whereas miRNAs are proposed to regulate gene expres-
sion by inhibiting protein synthesis through imperfect base-
pairing to the 3 UTR of target mRNAs (4, 5). Both siRNA and
miRNA precursors are processed to mature small RNAs in the
cytoplasm of cells by the large endonuclease Dicer (4, 8). Mature
miRNAs and siRNAs are assembled into miRISC and siRISC
(miRNA- and siRNA-induced silencing complexes, respec-
tively), which subsequently act on their targets by translational
repression or mRNA cleavage. Essential components of RISC
complexes are the members of the Argonaute family of proteins
(9). These proteins share the so-called PAZ and PIWI domains
and are classified into two subfamilies depending on sequence
similarity to either Arabidopsis Argonaute1 orDrosophila Piwi (9,
10). In mammals, Argonaute1 subfamily members, Ago1 to
Ago4, have been shown to be involved in the RNAimiRNA
pathway (11, 12). All four members of the PIWI subfamily are
expressed mainly in testis (10), and two of them, MIWI and
MILI, are crucial for progression through spermatogenesis in
mouse (13, 14).
In many organisms, including Drosophila, germ cells are
characterized by the accumulation of dense fibrous material into
a cytoplasmic structure, called germplasm or nuage (15). The
chromatoid body is suggested to be a mammalian counterpart of
nuage on the basis of its structural features and protein com-
position (16). It is a finely filamentous, lobulated perinuclear
granule located in the cytoplasm of mammalian postmeiotic
round spermatids. Both Drosophila nuage and mouse chroma-
toid body contain an ATP-dependent DEAD-box RNA helicase,
VASA [in the mouse MVH (mouse VASA homolog)] (17–19).
Drosophila nuage is thought to function as a site for translational
regulation of many important mRNAs, the VASA protein
seemingly playing a central role in this process (20). The role of
the chromatoid body in the mouse is still elusive, although it was
proposed to be involved in RNA storing and processing. In
addition to MVH, some other proteins have been reported to
localize in the chromatoid body, most of which are known to be
involved in RNA metabolism (16). Although there is no DNA in
the chromatoid body (21), the presence of RNA has been
suggested (22–25).
Here we demonstrate the physical relationship between the
chromatoid body and the miRNA machinery in haploid germ
cells. Dicer and components of miRISC (also referred to as
microRNP), such as various members of the Argonaute family
and several miRNA species, concentrate in the chromatoid body.
The presence of Dcp1a and other specific proteins in the
chromatoid body provides evidence of a functional analogy with
the processing bodies (P-bodies), cytoplasmic structures found in
somatic cells (ref. 26 and references therein).We have also found
that Dicer interacts with the VASA homolog MVH. These
findings shed new light on the function of the chromatoid body,
a structure whose existence has been known for decades (16) but
whose role has remained unknown. In addition, our results
underscore the importance of the miRNA pathway in the control
of postmeiotic male germ cell differentiation.
Results
Colocalization of the VASA Homolog MVH and MIWI in Chromatoid
Body. The highly restricted localization of MVH in the chroma-
toid body has been used as specific marker for this structure (18).
We confirmed this observation by performing immunostaining
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with anti-MVH antibodies on male germ cells isolated from
stages II–V of seminiferous epithelial cycle (Fig. 1A). Chroma-
toid bodies are clearly visible in parallel phase contrast micros-
copy as electron-dense areas (Fig. 1A). Using the drying-down
technique to prepare the cell slides, the cytoplasm is partially lost
to expose the chromatoid body, which usually stays in contact
with the nucleus.
We analyzed the formation of the chromatoid body along the
differentiation of postmeiotic germ cells. Stage-specific sequen-
tial squash preparations show MVH expression in chromatoid
bodies throughout the development of round spermatids (Fig.
1B). Expression is detected in the cytoplasm of pachytene
spermatocytes at stages IV–V within filamentous–granular
structures. In round spermatids, the chromatoid body becomes
finely compacted, and usually there is only one per cell. The
RNA-binding protein MIWI has been shown to have a granular
distribution in the cytoplasm of haploid round spermatids (14),
but it was unclear whether these granules corresponded to
chromatoid bodies. We demonstrate that MIWI is indeed con-
centrated in chromatoid bodies, colocalizing with MVH
(Fig. 1C).
Argonaute Proteins and P-body Components in the Chromatoid Body.
The presence of MIWI in chromatoid bodies prompted us to
analyze the localization of Ago subfamily members to establish
a possible relationship with the miRNA pathway. The function
of Ago proteins in male germ cells is presently unknown. Squash
preparations at stage IV showed a granular cytoplasmic local-
ization of Ago3 (Fig. 1D). Although Ago3 was diffused through-
out the cytoplasm, the signal was concentrated on one cytoplas-
mic spot in close contact with the nucleus (Fig. 1D). This granule
corresponds to the chromatoid body, as revealed by immuno-
fluorescence of germ cell slides and parallel phase contrast (Fig.
1E). Ago2 was also concentrated in the chromatoid body (Fig.
1F). It has been recently shown that in somatic cells Ago proteins
localize in cytoplasmic P-bodies (27–29). We therefore analyzed
the localization of a P-body marker, the decapping enzyme
component Dcp1a (30), in male germ cells. Strikingly, Dcp1a was
also concentrated in chromatoid bodies (Fig. 1 G and H). The
distribution of Dcp1a along spermatogenesis is dynamic. Al-
though it has a granular cytoplasmic localization in both meiotic
and postmeiotic germ cells, in late pachytene spermatocytes
there seem to be several Dcp1a granules (data not shown), which
then concentrate postmeiotically in the chromatoid body (Fig.
1H). Two other P-body markers, the 5-to-3 exonuclease Xrn1
(data not shown) and the RNA-binding protein GW182 (Fig. 1I)
(31), were also found in chromatoid bodies.
Because P-body components localize to the chromatoid body,
we questioned whether the male germ cell-specific MVH could
potentially be targeted to P-bodies in somatic cells. To this end,
FLAG-tagged MVH and HA-Ago2 or HA-Ago3 were ectopi-
cally expressed in HeLa cells. Indeed, MVH colocalized to the
same cytoplasmic granules with Ago2 and Ago3 (Fig. 6, which is
published as supporting information on the PNAS web site).
MVHmutants containing only the N terminus [FLAG-MVH(1–
199)] or lacking the central ATPase domain (FLAG-MVH283–
503) (see Fig. 5) failed to colocalize with Ago proteins (Fig. 6).
MVH-positive granules were shown to correspond to P-bodies by
coimmunostaining of endogenous Dcp1a (Fig. 6). Thus, the
P-bodies of somatic cells and the chromatoid body of male germ
cells share a number of significant similarities.
miRNAs Are Concentrated in Chromatoid Bodies. We performed in
situ hybridizations using probes specific for various miRNAs
known to be expressed in testis to study whether their localiza-
tion overlaps with Ago proteins in chromatoid bodies. The
analysis on squash preparation of stages V–VI, or drying-down
slides of germ cells from stages II–VI, revealed high concentra-
tion of miR-21 and let-7a in perinuclear granules in round
spermatids (Fig. 2 A–D). The signal overlapped with MVH
signal, clearly demonstrating that miRNAs accumulated in chro-
matoid bodies. miR-122a also colocalized with MVH in chro-
matoid body (Fig. 2E). A mutant let-7a probe, used as a negative
control, gave no signal (Fig. 2F). Interestingly, no enrichment of
signal was detected with the prelet7a RNA probe, indicating that
Fig. 1. Localization of MVH and Ago proteins in chromatoid body. (A)
Drying-down slides containing germ cells from stages II–V were labeled with
anti-MVH antibody (red). The localization in chromatoid body was confirmed
by parallel phase contrast microscopy. (B) Expression of MVH in chromatoid
bodies during spermatogenesis. Squash preparations from stages I, V, VII, IX,
and XII were stained with anti-MVH antibody (red) and studied by fluores-
cence microscopy. RS, round spermatid; PSc, pachytene spermatocyte; 2nd,
secondary spermatocyte; m, meiotic division. (C) Localization of MIWI in
chromatoid body. Germ cells from stages II–V were labeled with anti-MIWI
antibody. (D and E) Ago3 is concentrated in chromatoid bodies. Germ cell
squash preparations (D) at stage IV or drying-down slides containing germ
cells from stages II–V (E) were immunolabeled by polyclonal anti-Ago3 anti-
body (red). (F) Ago2 was also shown to be concentrated in chromatoid bodies
by using polyclonal anti-Ago2 antibody. (G and H) Localization of the P-body
marker, the decapping enzyme Dcp1a, in chromatoid bodies. Germ cell squash
preparations at stages III–IV (G) or drying-down slides from stages II–V (H) were
immunostained by polyclonal anti-Dcp1a antibody. (I) Chromatoid body lo-
calization of a GW body marker protein. Patient sera against human GW182
protein (18033; a gift from Marvin J. Fritzler, University of Calgary, Calgary,
Canada) were used for localization studies. For MVH detection, rabbit poly-
clonal anti-MVH antibody was used as a primary antibody. Alexa Fluor 594
anti-rabbit IgG or Alexa Fluor 488 anti-human IgG were used as secondary
antibodies, and DAPI was used to stain nuclei (blue). (Scale bars: 5 m.)
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it is primarily the processed form of let7a that localizes to
chromatoid bodies (Fig. 2G). Chromatoid body localization of
miR-128 and let-7a, but not of nontestis-expressed control
miRNA miR-206, was also demonstrated by in situ hybridization
of drying-down slides by using the colorimetric detection method
(Fig. 2H).
Localization of the RISC components and miRNAs in chro-
matoid bodies motivated us to study whether mRNA molecules,
the natural targets for miRNA-mediated regulation, also con-
centrate in chromatoid bodies. In situ hybridization using oli-
go(dT) probe clearly demonstrated accumulation of mRNAs in
chromatoid bodies (Fig. 3 A and B). Interestingly, antibodies
specifically recognizing rRNA did not stain chromatoid body
(Fig. 3C); likewise, antibodies recognizing the small ribosomal
subunit protein S6 showed no signal overlapping with the
MVH-positive chromatoid bodies (data not shown), indicating
that active translation at this specific stage of spermatogenesis
occurs in locations distinct from chromatoid bodies.
Dicer Is Concentrated in the Chromatoid Body. The presence of Ago
proteins and miRNAs in the chromatoid body directed us to
study Dicer expression during spermatogenesis. Dicer is present
in bothmeiotic spermatocytes and postmeiotic round spermatids
but not in elongated spermatids (Fig. 4A). Expression is constant
along the stages of the seminiferous epithelial cycle (Fig. 4A).
We have also established that the Dicer protein in testis is
enzymatically active (Fig. 4B). Immunostaining of germ cell
slides from specific stages revealed that the expression of Dicer
is indeed concentrated in chromatoid bodies (Fig. 4C). Finally,
a detailed analysis along the differentiation of male germ cells
shows a stage-dependent distribution of Dicer in the chromatoid
body: In step 1 round spermatids, Dicer expression is still very
low, but it increases at stages VI–VII. At stage VIII, Dicer levels
in the chromatoid body decrease significantly. Thus, Dicer
localization to the chromatoid body is highly dynamic, being at
its peak coordinately with the other elements of the miRNA
machinery.
Dicer Interacts with the VASA Homolog MVH. Although Dicer is
known to interact with other proteins involved in RNA silencing
(refs. 32 and 33 and references therein), its presence in the
chromatoid body raised the possibility that it could interact with
germ cell-specific elements, in particular MVH. FLAG-tagged
MVH and EGFP-tagged Dicer were ectopically coexpressed in
COS-1 cells and then coimmunoprecipitated (Fig. 5A). We
found that MVH and Dicer interact. We have used a number of
Fig. 2. Localization of miRNA in chromatoid bodies. (A–G) In situ hybridiza-
tion was performed with DIG-labeled locked nucleotide probes specific for
different miRNAs. Except in A and C, samples fixed by the drying-down
method were used for analysis. In A and C, squashed samples from stage II–VI
seminiferous tubules were used. The miRNA-specific probes used in each panel
are indicated. The prelet-7a probe was designed to detect the prelet-7a but
not the mature let-7a. let-7a Mut is a mutant version of let-7a-specific probe.
After in situ hybridization, miRNA signals were detected with the Roche
fluorescent antibody enhancer set for DIG detection (red). MVH signals are in
green, and the nucleus was stained with DAPI (blue). The merged pictures are
also shown. (H) detection of miRNA by the colorimetric method. miR-206-
specific probe is used as a negative control. (Scale bars: 5 m.)
Fig. 3. Poly(A) RNA is concentrated in chromatoid bodies. A Cy3-labeled
oligo(dT) probe was used to detect mRNAs with a polyA tail in cells fixed by the
drying-down method (A) and also in cells of stage V–VII squash preparations
(B). After in situ hybridization with Cy3-labeled oligo(dT), MVH signals were
revealed by immunofluorescence (green). DAPI was used to stain the nucleus.
(C) Ribosomal RNA localization in round spermatids. Ribosomes localized to
cytoplasmic regions (red) distinct from the chromatoid body positive for MVH
(green). (Scale bars: 5 m.)
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MVHdeletions to establish the protein domain involved in Dicer
interaction (Fig. 5 A and B). The mutants MVH(1–199) and
MVH(1–496) did not interact with Dicer, despite containing the
central ATPase motif and the N-terminal RGGQGG repeats
known to be involved in proteinRNA interactions (17). This
result shows that the C terminus of MVH, which contains a
RNA-binding domain (17), is required for Dicer interaction (Fig.
5A). Interestingly, the MVH284–503 deletion, which lacks the
central ATPase motif, interacts with Dicer more efficiently than
the full-lengthMVH protein. This finding may suggest a negative
regulatory role of this region in controlling the interaction with
Dicer.
Dicer is a multidomain protein that includes a RNA helicase
ATPase domain, the DUF283 and PAZ signatures, two neigh-
boring RNase III-like domains, and a dsRNA binding domain
(34). Our coimmunoprecipitation experiments demonstrate that
the C-terminal RNaseIII region is sufficient for interaction with
MVH (Fig. 5C). In support of this observation, a large portion
of the Dicer protein containing the N-terminal ATPasehelicase
domains and the central PAZ signatures did not interact with
MVH (Fig. 5C andD). Interestingly, HIWI, the human homolog
of mouse MIWI, has also been shown to interact with the C
terminus of Dicer (32). This interaction was used as a positive
control (data not shown). Finally, the direct interaction between
MVH and Dicer was confirmed by in vitro interaction assays by
using bacterially generated recombinant GST-MVH and Dicer-
6xHis (Fig. 5E). Thus, MVH appears to be a male germ
cell-specific component of the Dicer complex.
Discussion
The molecular nature and function of the chromatoid body in
germ cells have been elusive and debated for many years (16).
Fig. 4. Localization of Dicer in chromatoid body. (A) Expression of Dicer
protein in testis. Western blot analysis of the protein extracts of rat total testis
cells (T), pachytene spermatocytes (Sc), round spermatids (RS), and elongated
spermatids (ES), as well as of different stages of the rat seminiferous epithelial
cycle (indicated as Roman numerals I–XIV), was performed by using anti-Dicer
antibody. (B) premiRNA-processing activity in testis. prelet-7a substrate was
processed when testis extract (Lys) or anti-Dicer immunoprecipitate (IP) was
added to the reaction. Reaction with recombinant Dicer (D) was used as a
positive control. (C) Dicer is expressed in the chromatoid body of late round
spermatids. The drying-down slides were immunostained with the anti-Dicer
349 antibody and studied by both fluorescence microscopy (red, Dicer; blue,
DNA) and phase contrast microscopy to confirm the chromatoid body local-
ization. Similar staining was obtained with anti-Dicer 350 antibody. (Scale
bars: 10 m.)
Fig. 5. Dicer interacts with MVH. (A) Interaction of the full-length EGFP-
Dicer with MVH. IP was performed from COS-1 lysates overexpressing EGFP-
Dicer and FLAG-MVH, FLAG-MVH(1–199), FLAG-MVH(1– 496), or FLAG-
MVH284–503 with anti-FLAG antibody (-FL), and the immunoblotting was
performed by using either anti-Dicer antibody to detect coimmunoprecipi-
tated Dicer or anti-FLAG antibody to detect MVH. (B) Schematic diagram of
the MVH constructs used in this study. (C) The RNaseIII region of Dicer mediates
the interaction with MVH. GST, GST-HelicasePAZ containing the N-terminal
helicase domain and the central PAZ domain of Dicer (HPAZ), or GST-RNaseIII
containing the C-terminal RNaseIII region and dsRNA binding domain of Dicer
(RIII) was coexpressed with FLAG-MVH. After immunoprecipitation with anti-
FLAG antibody, immunoblotting was done with anti-GST or anti-FLAG anti-
body. An asterisk indicates the IgG light chain. (D) Schematic representation
of the Dicer mutants used in this study. (E) MVH and Dicer interact in vitro.
Recombinant GST-MVH and Dicer-6xHis were incubated with glutathione
Sepharose. After binding and washes, beads were run into a polyacrylamide
gel, and immunoblotting was performed with anti-GST or anti-Dicer antibody.
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Our findings support a scenario where the chromatoid body
would function as an RNA storing and processing structure.
Specifically, the presence of DicerArgonaute and miRNAs
reveals that the chromatoid body occupies a privileged position
in posttranscriptional control of gene expression through the
small RNAs pathway.
To date, very little was known about the function of siRNA
and miRNA pathways and the expression and localization of the
components of these pathways during spermatogenesis. RNAi
has been shown to be active during the whole spermatogenesis
program (7), and many miRNAs whose expression is enriched in
testis have been identified (35, 36). Here we demonstrate that the
main component of the RNA-silencing pathway, Dicer, is ex-
pressed in both meiotic and postmeiotic cells at all stages of the
seminiferous epithelial cycle.
Dicer processes miRNA precursor molecules folded into
dsRNA-like hairpins to mature miRNAs. These are subse-
quently transferred to the miRISC complex, where the effector
phase of the process takes place (4, 8). A direct interaction
between Dicer and Ago proteins may be required for the transfer
of miRNAs to the effector complex (8). The presence in the
chromatoid body of several miRNAs, of the enzyme that pro-
cesses them, and of proteins essential for the effector phase of
mRNA silencing strongly supports the notion that functional
miRNA-mediated mRNA control is taking place in this com-
partment. Interestingly, a potential connection between germ-
plasm (nuage) and miRNA pathway has also been suggested in
Drosophila. Indeed, mutation of the nuage protein Maelstrom
causes mislocalization of two miRNA pathway proteins, Dicer
and Ago2 (37).
MIWI, a member of the PIWI subfamily of Argonaute pro-
teins, localizes to the chromatoid body (Fig. 1). Argonaute1
subfamily members are widely expressed in many tissues. In
contrast, all four members of PIWI subfamily are expressed
mainly in testis (10), but their role in the RNAi pathway is still
obscure (9). MIWI associates with ribohomopolymers, and
specifically with transcripts of CREM-target genes, suggesting a
functional connection of MIWI to RNA processing (13). Im-
portantly, mice deficient for either MIWI or CREM display a
similar block in spermatogenesis (13, 38). BecauseMIWI and the
Argonaute1 subfamily members Ago2 andAgo3 colocalize in the
chromatoid body (Fig. 1), it is tempting to speculate that MIWI
may operate as a male germ cell-specific miRNA pathway
component involved in functional mRNA regulation in testis.
In yeast and mammalian somatic cells, mRNAs targeted to
translational repression and degradation accumulate in cyto-
plasmic P-bodies, where the enzymes involved in the RNA decay
pathway are also concentrated (30, 39–41). Recently, Ago
proteins, and also miRNAs and miRNA-repressed mRNAs,
were demonstrated to localize in P-bodies in mammalian cells
(27–29), suggesting that RNA silencing and RNA decay path-
ways may take place in the same cellular compartments. The
current model proposes that mammalian miRNAs inhibit the
initiation of translation of mRNAs that subsequently accumulate
in P-bodies for storage (29). We have demonstrated that several
P-body markers are highly concentrated in chromatoid bodies
(Fig. 1). These results suggest that the chromatoid body of male
germ cells and P-bodies in somatic cells are functionally related,
both acting as a site for mRNA decay and mRNA translational
repression by the miRNA pathway. Thus, our findings provide an
attractive interpretation of the phenomenon of translational
repression that occurs postmeiotically in spermatids (42, 43).
One significant result reported here is that an essential
component of the chromatoid body, the RNA helicaseATPase
MVH, interacts with Dicer. MVH may operate as an anchoring
element for RNA-silencing components, or it might have a more
functional role. Interestingly, the turnover of the RISC cleavage
activity depends on ATP, suggesting that release of the cleaved
mRNA halves may involve RNA helicases (8, 44). Thus, our
finding reveals MVH as a potential germ cell-specific candidate
for providing helicaseATPase activity to the RISC complex.
The chromatoid body is endowed with the remarkable prop-
erty of moving very actively and three-dimensionally in the
cytoplasm of round spermatids. During these movements chro-
matoid bodies make frequent contacts with the nuclear enve-
lope. Continuity in electron-dense material between the nucleus
and the chromatoid body through nuclear pore complexes has
been observed (16). One hypothesis suggests that rapidly moving
chromatoid bodies collect mRNA getting out from the nucleus.
Interestingly, miRNA precursors processed in the nucleus are
exported to the cytoplasm through nuclear pore complexes (45).
Based on our findings we suggest a model in which premiRNAs
transported to the cytoplasm are loaded through nuclear pores
to the chromatoid body. Thus, the chromatoid body functions as
a subcellular concentration site for components of the miRNA
pathway, centralizing the miRNA posttranscriptional control
system in the cytoplasm of haploid male germ cells.
Materials and Methods
Immunofluorescence. Squash preparations or drying-down slides
(46) were fixed in 4% paraformaldehyde, and immunofluores-
cence was performed by using specific polyclonal or monoclonal
antibodies and Alexa Fluor 594 and 488 secondary antibodies
(Molecular Probes).
miRNA in Situ. Locked nucleotide probes were labeled with
digoxigenin (DIG) by using the terminal transferase 3 DIG-
tailing kit (Roche). Fixed cells were permeabilized in 70%
ethanol, rehydrated in 2 SSC for 15 min, and hybridized
overnight at 37°C with 15 ng of the probe. After three washes,
slides were incubated with anti-DIG alkaline phosphate-
conjugated Fab fragment (1:5,000; Roche), and signals were
developed with nitroblue tetrazolium and 5-bromo-4-chloro-3-
indolyl phosphate in the dark. In colocalization studies the
Fluorescent Antibody Enhancer Set for DIG Detection (Roche)
was used.
RNA Processing Assays. The internally 32P-labeled prelet-7 RNA
was dissolved in water and renaturated by incubation at 90°C for
1 min. Processing assays (50 l) were carried out as previously
described in refs. 34 and 47. 32P-labeled substrate (3–5 fmol) was
incubated with a testis extract or anti-Dicer immunoprecipitate
in buffer containing 20 mM TrisHCl (pH 7.5), 2 mM MgCl2, 75
mM NaCl, and 10% glycerol at 37°C. RNA was extracted with
phenolchloroform and analyzed by 10% denaturing PAGE.
Immunoprecipitation. COS-1 cells transfected with indicated plas-
mids were collected and lysed in a buffer containing 50 mM
TrisHCl (pH 8.0), 170 mM NaCl, 5 mM EDTA, 0.5% Nonidet
P-40, 1 mM DTT, and 1:1,000 protease inhibitor mixture.
Immunoprecipitation was performed with anti-FLAG M2
(Sigma) monoclonal antibody and protein G Sepharose (Amer-
sham Pharmacia Biosciences). After washes, proteins were re-
leased in 2 Laemmli sample buffer. Immunoblotting was
performed by anti-GST (1:1,000), anti-FLAG M2 (1:1,000), or
anti-Dicer 349 (1:1,000) antibody.
Recombinant Proteins and in Vitro Interaction. Recombinant GST-
MVH was purified from the BL21 Escherichia coli strain with
glutathione Sepharose (Amersham Pharmacia) and eluted from
the beads with 20 mM glutathione. Recombinant Dicer was
purified as described (47). In vitro protein interactions with
recombinant proteins were analyzed in buffer containing 30 mM
TrisHCl (pH 7.5), 1 mM MgCl2, 100 mM NaCl, and 0.5%
Nonidet P-40 by using standard methods.
Specific reagents and detailed additional procedures are fully
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described in Supporting Materials and Methods, which is pub-
lished as supporting information on the PNAS web site.
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